Background Image
Previous Page  161 / 182 Next Page
Information
Show Menu
Previous Page 161 / 182 Next Page
Page Background

160

http://www.DGS-PraxisLeitlinien.de

Nr.

Nachweis

97

Ferrell BR, Juarez G, Borneman T. Use of routine and breakthrough analgesia in home

care. Oncology Nursing Forum 1999; 26: 1655-1661.

98

Fine PG, Busch MA. Characterization of breakthrough pain by hospice patients and their

caregivers. Journal of Pain and Symptom Management 1998; 16(3): 179-183.

99

Fine PG, Herr KA. Efficacy, safety and tolerability of pharmacotherapy for management

of persistent pain in older persons. Annals of Long-term Care: Clinical Care and Aging

2006; 14(3): 25-33.

100

Fine PG, Messina J, Xie F, Rathmell J. Long-term safety and tolerability of fentanyl buccal

tablet for the treatment of breakthrough pain in opioid-tolerant patients with chronic

pain: an 18-month study. J Pain Symptom Manage 2010; 40(5): 747-760.

101

Fine PG. The diagnosis and treatment of breakthrough pain. Oxford University Press,

2008.

102

Fine PG. The evolving and important role of anesthesiology in palliative care. Anesthe-

sia and Analgesia 2005; 100: 183-188.

103

Finn AL, Vasisht N, Stark JG, Gever LN, Tagarro I. Dose proportionality and pharmacoki-

netics of fentanyl buccal soluble film in healthy subjects: a phase I, open-label, three-

period, crossover study. Clin Drug Investig 2012; 32(1): 63-71.

104

Fisher A, Watling M, Smith A, Knight A.  Pharmacokinetics and relative bioavailability of

fentanyl pectin nasal spray 100-800 mg in healthy volunteers. Int J Clin Pharmacol Ther

2010; 48 (12): 860-867.

105

Fisher HB, Peters TM, Fleming IM, Else TA. Peripheral nerve catheterization in the ma-

nagement of terminal cancer pain. Regional Anesthesia 1996; 21: 482-485.

106

Foley KM. Acute and chronic cancer pain syndromes. In: Doyle D, Hanks G, Cherny N,

Calman K (Hrsg.), Oxford Textbook of Palliative Medicine (3. Aufl., pp. 298-316). Oxford:

Oxford University Press 2004.

107

Fortner BV, Demarco G, Irving G, Ashley J, Keppler G, Chavez J, Munk J. Description and

predictors of direct and indirect costs of pain reported by cancer patients. Journal of

Pain and Symptom Management 2003; 25(1): 9-18.

108

Fortner BV, Okon TA, Portenoy RK. A survey of pain-related hospitalizations, emergen-

cy department visits, and physician office visits reported by cancer patients with and

without history of breakthrough pain. Journal of Pain 2002; 3(1): 38-44.

109

Fourney DR, Schomer DF, Nader R, Chlan-Fourney J, Suki D, Ahrar K, Rhines LD,

Gokaslan ZL. Percutaneous vertebroplasty and kyphoplasty for painful vertebral body

fractures in cancer patients. Journal of Neurosurgery 2003; 98 (Suppl): 21-30.

110

Freye E, Levy JV, Braun D. Effervescent morphine results in faster relief of breakthrough

pain in patients compared to immediate release morphine sulfate tablet. Pain Practice

2007; 7: 324-331.

111

Friedrichsdorf SJ, Finney D, Bergin M, Stevens M, Collins JJ. Breakthrough pain in child-

ren with cancer. J Pain Symptom Manage. 2007; 34(2): 209-216.

Literaturverzeichnis